Publications (62) OCTAVIO CABA PÉREZ publications

2023

  1. Nutritional status assessment in patients with chronic pancreatitis

    Progress in Nutrition, Vol. 25, Núm. 4

  2. Predicting COVID-19 Severity Integrating RNA-Seq Data Using Machine Learning Techniques

    Current Bioinformatics, Vol. 18, Núm. 3, pp. 221-231

  3. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma

    World Journal of Gastrointestinal Oncology, Vol. 15, Núm. 2, pp. 268-275

  4. Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis

    NMR in Biomedicine, Vol. 36, Núm. 9

  5. Study of SARS-CoV-2 in semen from asymptomatic donors with the presence of virus in nasopharyngeal swabs

    Reproductive BioMedicine Online, Vol. 47, Núm. 6

2022

  1. Chronic pancreatitis: analysis of disease progression factors

    Revista Medica de Chile, Vol. 150, Núm. 12, pp. 1555-1564

2021

  1. Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  2. Importance of BRCA mutation for the current treatment of pancreatic cancer beyond maintenance

    World Journal of Gastroenterology, Vol. 27, Núm. 39, pp. 6515-6521

  3. Liquid biopsy approach to pancreatic cancer

    World Journal of Gastrointestinal Oncology, Vol. 13, Núm. 10, pp. 1263-1287

  4. Untargeted metabolomics for the diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis

    Medicina (Lithuania), Vol. 57, Núm. 9

2020

  1. Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics

    Cancers, Vol. 12, Núm. 4

  2. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

    Journal of Biosciences, Vol. 45, Núm. 1

  3. Novel biomarkers to distinguish between type 3c and type 2 diabetes mellitus by untargeted metabolomics

    Metabolites, Vol. 10, Núm. 11, pp. 1-12

  4. Role of exocrine and endocrine insufficiency in the management of patients with chronic pancreatitis

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-12

  5. State of the art in exocrine pancreatic insufficiency

    Medicina (Lithuania), Vol. 56, Núm. 10, pp. 1-10

  6. Towards Improving Skin Cancer Diagnosis by Integrating Microarray and RNA-Seq Datasets

    IEEE Journal of Biomedical and Health Informatics, Vol. 24, Núm. 7, pp. 2119-2130

2019

  1. Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level

    PLoS ONE, Vol. 14, Núm. 2

  2. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

    PLoS ONE, Vol. 13, Núm. 4

  2. Proteomic biomarkers in body fluids associated with pancreatic cancer

    Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587